NEW YORK, NY--(Marketwire - November 13, 2008) - Daxor Corporation (AMEX: DXR), a medical instrumentation and biotechnology company, today announced third quarter earnings for 2008. For the quarter ended September 30, 2008, total operating revenues increased by 29.1 % to $451,253 from $349,547 for the same period in 2007. This was mainly the result of one Blood Volume Analyzer being sold during the current quarter for $65,000 versus no Blood Volume Analyzers sold during the same period last year. During the current quarter, Volumex kit sales increased by $28,423 or 12.7% versus the same period in 2007.
